Xiaojun Shi
- Pharmaceutical Science top 5%
- Biochemistry top 10%
- Biomaterials top 10%
- Dermatology top 5%
- Skin Protection and Aging 4
- Reproductive Medicine top 10%
-
- Bladder and Urothelial Cancer Treatments 5
-
- Cancer Immunotherapy and Biomarkers 4
-
- Hepatitis B Virus Studies 3
- Liver Disease Diagnosis and Treatment 3
-
- Gastroesophageal reflux and treatments 2
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 2
-
- RNA Interference and Gene Delivery 2
- Journals
- SHILAP Revista de lepidopterología (1 paper)Nano Letters (1 paper)British Journal of Pharmacology (1 paper)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Xiaojun Shi
37 papers receiving 936 citations
Peers
Comparison fields: 5 of 106
- Pharmaceutical Science 115
- Biochemistry 78
- Biomaterials 170
- Dermatology 114
- Reproductive Medicine 52
Countries citing papers authored by Xiaojun Shi
This map shows the geographic impact of Xiaojun Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojun Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojun Shi more than expected).
Fields of papers citing papers by Xiaojun Shi
This network shows the impact of papers produced by Xiaojun Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojun Shi. The network helps show where Xiaojun Shi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaojun Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 12 | |
| 4 | 2023 | 0 | |
| 5 | 2023 | 8 | |
| 6 | 2023 | 9 | |
| 7 | 2022 | 9 | |
| 8 | 2021 | 7 | |
| 9 | 2021 | 2 | |
| 10 | 2021 | 4 | |
| 11 | 2021 | 21 | |
| 12 | 2020 | 7 | |
| 13 | 2018 | 8 | |
| 14 | 2017 | 151 | |
| 15 | 2016 | 4 | |
| 16 | 2015 | 63 | |
| 17 | 2014 | 36 | |
| 18 | 2013 | 116 | |
| 19 | 2011 | 29 | |
| 20 | 2010 | 19 |
About Xiaojun Shi
Xiaojun Shi is a scholar working on Dermatology, Hepatology and Gastroenterology, having authored 40 papers that have together received 947 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (5 papers), Skin Protection and Aging (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Hepatitis B Virus Studies (3 papers), Liver Disease Diagnosis and Treatment (3 papers), Gastroesophageal reflux and treatments (2 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and RNA Interference and Gene Delivery (2 papers). The work is most often cited by research in Pharmaceutical Science (115 citations), Biochemistry (78 citations) and Biomaterials (170 citations). Xiaojun Shi has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Houjie Chen, Li Ding, Xianbing Zhu, Dawei Chen, Sheng‐Tao Hou, Haiyang Hu, Yong‐yuan Zhu, Zhi‐Xiu Lin, Wei Tao and Xiang Ling. Their work appears in journals such as SHILAP Revista de lepidopterología, Nano Letters and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.